Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tirzepatide is sold as Zepbound for chronic weight management and as Mounjaro for type 2 diabetes, working as a dual GLP-1/GIP receptor agonist that targets both the GLP-1 and GIP receptors instead of GLP-1 alone, which enhances fat metabolism and insulin sensitivity beyond a single-receptor peptide
Fox News senior medical analyst Dr
Tirzepatide is prescription-only
Because Mounjaro can cause side effects similar to symptoms of vitamin deficiency, such as nausea and fatigue, it can be difficult to distinguish between the medications side effects and a genuine nutritional deficiency
US$ 28.40
US$ 29.67
US$ 23.89
US$ 27.11
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
